journal article·2014-07-24Open access

Polymeric nanocarrier systems for photodynamic therapy

Li Li, Kang Moo Huh

Biomaterials Research· Volume 18· Issue 1

Abstract

Abstract Photodynamic therapy (PDT) is an emerging treatment modality that involves the combined action of photosensitizers (PSs) and light for treatment of solid tumor and other diseases. Although this therapeutic method has been considered as an alternative to classical cancer treatments, clinical PDT requires further advances in selectivity and therapeutic efficacy to overcome numerous shortages related to conventional PDT. In this regard, great efforts have been devoted to the development of polymeric nanocarrier-encapsulated PSs for targeted PDT, aiming at improvement of water solubility and tumor-specificity of hydrophobic PSs. Here, we discuss the general concepts and considerations of polymeric nanocarriers for efficient delivery of PSs. In recent, the amphiphilic PS-polymer conjugate-based self-quenchable nanoparticles and PS-polymer-conjugate/quencher nanocomplexes have emerged as an attractive delivery platform for efficient and reliable PDT. They can incorporate and deliver the PS in a photodynamically inactive state but demonstrate cytotoxic effects by tumor environment-sensitive activation mechanisms, so that the photodynamic cancer treatment can achieve maximum target specificity. Here, we report the recent achievements on the development of activatable PS formulations based on PS-polymer conjugates.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Nanoplatforms for cancer theranostics · Photodynamic Therapy Research Studies · Porphyrin and Phthalocyanine Chemistry

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Polymer Science and Engineering, Chungnam National University, 99 Daehak-ro, Yuseong-gu, Daejeon 305-764, Republic of Korea.

References (88)

Show source-provided references
1. Hamblin MR, Mróz P: Advances in Photodynamic Therapy : Basic, Translational, and Clinical. Boston, Mass: Artech House; 2008.
2. Juarranz A, Jaen P, Sanz-Rodriguez F, Cuevas J, Gonzalez S: Photodynamic therapy of cancer. Basic principles and applications. Clin Transl Oncol Off Publ Federation Spanish Oncol Soc National Cancer Institute Mexico 2008, 10:148–154.
3. 10.1002/jpp.32810.1002/jpp.328 ↗
4. 10.1093/jnci/90.12.88910.1093/jnci/90.12.889 ↗
5. Zimcik P, Miletin M: Photodynamic therapy as a new prospective method for cancer treatment. I. History, basic principles. Ceska Slovenska Farmacie Casopis Ceske Farmaceuticke Spolecnosti Slovenske Farmaceuticke Spolecnosti 2004, 53:219–224.
6. Wilson BC: Photodynamic therapy for cancer: principles. Can J Gastroenterol J Can Gastroenterol 2002, 16:393–396.10.1155/2002/743109 ↗
7. 10.1038/nrc107110.1038/nrc1071 ↗
8. 10.1016/S1011-1344(96)07372-110.1016/S1011-1344(96)07372-1 ↗
9. 10.1016/S1470-2045(05)70263-110.1016/S1470-2045(05)70263-1 ↗
10. 10.1007/978-1-60761-697-9_1810.1007/978-1-60761-697-9_18 ↗
11. 10.1038/bjc.1996.51610.1038/bjc.1996.516 ↗
12. 10.1007/s11934-003-0073-410.1007/s11934-003-0073-4 ↗
13. 10.1016/S0007-1226(95)90065-910.1016/S0007-1226(95)90065-9 ↗
14. 10.1111/j.1365-2230.2011.04248.x10.1111/j.1365-2230.2011.04248.x ↗
15. 10.1016/S1011-1344(01)00267-610.1016/S1011-1344(01)00267-6 ↗
16. Nowis D, Makowski M, Stoklosa T, Legat M, Issat T, Golab J: Direct tumor damage mechanisms of photodynamic therapy. Acta Biochim Pol 2005, 52:339–352.10.18388/abp.2005_3447 ↗
17. Milla Sanabria L, Rodriguez ME, Cogno IS, Rumie Vittar NB, Pansa MF, Lamberti MJ, Rivarola VA: Direct and indirect photodynamic therapy effects on the cellular and molecular components of the tumor microenvironment. Biochim Biophys Acta 1835, 2013:36–45.
18. Krammer B: Vascular effects of photodynamic therapy. Anticancer Res 2001, 21:4271–4277.
19. Vancikova Z: Principles of the photodynamic therapy and its impact on the immune system. Sb Lek 1998, 99:1–11.
20. 10.1016/S1572-1000(05)00098-010.1016/S1572-1000(05)00098-0 ↗
21. 10.1021/jm040074b10.1021/jm040074b ↗
22. 10.1111/j.1751-1097.2009.00585.x10.1111/j.1751-1097.2009.00585.x ↗
23. 10.1039/B915149B10.1039/B915149B ↗
24. Daicoviciu D, Filip A, Ion RM, Clichici S, Decea N, Muresan A: Oxidative photodamage induced by photodynamic therapy with methoxyphenyl porphyrin derivatives in tumour-bearing rats. Folia Biol 2011, 57:12–19.10.14712/fb2011057010012 ↗
25. 10.1111/j.1751-1097.1991.tb08468.x10.1111/j.1751-1097.1991.tb08468.x ↗
26. 10.1111/j.1751-1097.1986.tb05648.x10.1111/j.1751-1097.1986.tb05648.x ↗
27. 10.1039/c3pp50393c10.1039/c3pp50393c ↗
28. 10.1016/j.jinorgbio.2009.12.01110.1016/j.jinorgbio.2009.12.011 ↗
29. Kreimer-Birnbaum M: Modified porphyrins, chlorins, phthalocyanines, and purpurins: second-generation photosensitizers for photodynamic therapy. Semin Hematol 1989, 26:157–173.
30. 10.1021/jo060041z10.1021/jo060041z ↗
31. Vrouenraets MB, Visser GW, Snow GB, van Dongen GA: Basic principles, applications in oncology and improved selectivity of photodynamic therapy. Anticancer Res 2003, 23:505–522.
32. 10.1016/0140-6736(93)92789-V10.1016/0140-6736(93)92789-V ↗
33. 10.1016/S0959-8049(01)00171-X10.1016/S0959-8049(01)00171-X ↗
34. 10.1016/j.addr.2003.07.01410.1016/j.addr.2003.07.014 ↗
35. 10.2174/0929867311320999021110.2174/09298673113209990211 ↗
36. 10.1016/j.jconrel.2011.09.08510.1016/j.jconrel.2011.09.085 ↗
37. 10.1080/0265204060077552510.1080/02652040600775525 ↗
38. 10.1016/j.ijpharm.2005.10.04810.1016/j.ijpharm.2005.10.048 ↗
39. 10.1016/j.addr.2008.08.00310.1016/j.addr.2008.08.003 ↗
40. 10.1007/978-1-61779-052-2_1110.1007/978-1-61779-052-2_11 ↗
41. 10.2147/IJN.S3961510.2147/IJN.S39615 ↗
42. 10.1211/002235701177535210.1211/0022357011775352 ↗
43. 10.1021/bm500040710.1021/bm5000407 ↗
44. 10.1039/c0cc01413c10.1039/c0cc01413c ↗
45. 10.1016/j.addr.2003.07.01310.1016/j.addr.2003.07.013 ↗
46. 10.1016/S0065-2571(00)00013-310.1016/S0065-2571(00)00013-3 ↗
47. Nehoff H, Parayath NN, Domanovitch L, Taurin S, Greish K: Nanomedicine for drug targeting: strategies beyond the enhanced permeability and retention effect. Int J Nanomedicine 2014, 9:2539–2555.
48. 10.1021/bc100116v10.1021/bc100116v ↗
49. 10.1016/j.biomaterials.2010.04.03010.1016/j.biomaterials.2010.04.030 ↗
50. 10.1016/j.carbpol.2011.05.01110.1016/j.carbpol.2011.05.011 ↗
51. 10.1016/j.biomaterials.2013.05.01710.1016/j.biomaterials.2013.05.017 ↗
52. 10.1021/bm500361910.1021/bm5003619 ↗
53. 10.1016/j.biomaterials.2011.07.02310.1016/j.biomaterials.2011.07.023 ↗
54. 10.1016/j.jconrel.2013.07.00210.1016/j.jconrel.2013.07.002 ↗
55. 10.1039/c4tb00181h10.1039/c4tb00181h ↗
56. Matsumura Y, Maeda H: A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs. Cancer Res 1986, 46:6387–6392.
57. Maeda H, Matsumura Y: Tumoritropic and lymphotropic principles of macromolecular drugs. Crit Rev Ther Drug Carrier Syst 1989, 6:193–210.
58. 10.1562/2005-09-01-RA-66910.1562/2005-09-01-RA-669 ↗
59. 10.1111/j.1751-1097.1996.tb05670.x10.1111/j.1751-1097.1996.tb05670.x ↗
60. 10.2174/09298670677636088810.2174/092986706776360888 ↗
61. 10.1111/j.1751-1097.1993.tb02962.x10.1111/j.1751-1097.1993.tb02962.x ↗
62. Namiki Y, Namiki T, Date M, Yanagihara K, Yashiro M, Takahashi H: Enhanced photodynamic antitumor effect on gastric cancer by a novel photosensitive stealth liposome. Pharmacol Res Off J Ital Pharmacol Soc 2004, 50:65–76.
63. 10.1517/1742524080244467310.1517/17425240802444673 ↗
64. 10.1007/978-1-60761-609-2_1110.1007/978-1-60761-609-2_11 ↗
65. 10.1016/S1359-6446(05)03575-010.1016/S1359-6446(05)03575-0 ↗
66. 10.1615/CritRevTherDrugCarrierSyst.v25.i5.1010.1615/CritRevTherDrugCarrierSyst.v25.i5.10 ↗
67. 10.1016/j.colsurfb.2009.09.00110.1016/j.colsurfb.2009.09.001 ↗
68. 10.1111/j.2042-7158.1995.tb05815.x10.1111/j.2042-7158.1995.tb05815.x ↗
69. 10.1016/S0928-0987(03)00017-410.1016/S0928-0987(03)00017-4 ↗
70. 10.1016/S0939-6411(02)00128-510.1016/S0939-6411(02)00128-5 ↗
71. 10.1517/17425247.3.1.13910.1517/17425247.3.1.139 ↗
72. 10.1016/j.pharmthera.2006.05.00610.1016/j.pharmthera.2006.05.006 ↗
73. 10.1111/j.1751-1097.2007.00194.x10.1111/j.1751-1097.2007.00194.x ↗
74. 10.1021/mp100060v10.1021/mp100060v ↗
75. 10.1039/b811248g10.1039/b811248g ↗
76. 10.1016/j.ijpharm.2014.05.06410.1016/j.ijpharm.2014.05.064 ↗
77. 10.1016/j.colsurfb.2014.01.00110.1016/j.colsurfb.2014.01.001 ↗
78. 10.1038/nbt117510.1038/nbt1175 ↗
79. 10.1016/j.biomaterials.2013.09.07510.1016/j.biomaterials.2013.09.075 ↗
80. 10.1074/jbc.M109.05497310.1074/jbc.M109.054973 ↗
81. Ryumina AP, Serebrovskaya EO, Shirmanova MV, Snopova LB, Kuznetsova MM, Turchin IV, Ignatova NI, Klementieva NV, Fradkov AF, Shakhov BE, Zagaynova EV, Lukyanov KA, Lukyanov SA: Flavoprotein miniSOG as a genetically encoded photosensitizer for cancer cells. Biochim Biophys Acta 1830, 2013:5059–5067.
82. 10.2174/09298671079320545310.2174/092986710793205453 ↗
83. 10.1021/cr900236h10.1021/cr900236h ↗
84. 10.1039/c0pp00147c10.1039/c0pp00147c ↗
85. 10.1002/cmdc.20060024410.1002/cmdc.200600244 ↗
86. 10.1021/jp810324v10.1021/jp810324v ↗
87. 10.1016/j.biomaterials.2011.02.00910.1016/j.biomaterials.2011.02.009 ↗
88. 10.3109/1354750X.2012.71567210.3109/1354750X.2012.715672 ↗